Symbols / CBLL Stock $20.50 +1.69% CeriBell, Inc.

Healthcare • Medical Devices • United States • NMS
CBLL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Xingjuan Chao Ph.D.
Exch · Country NMS · United States
Market Cap 776.39M
Enterprise Value 634.66M
Income -53.41M
Sales 89.06M
FCF (ttm) -23.60M
Book/sh 4.14
Cash/sh 4.23
Employees 327
Insider 10d —
IPO Oct 11, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -20.39
PEG —
P/S 8.72
P/B 4.95
P/C —
EV/EBITDA -11.12
EV/Sales 7.13
Quick Ratio 9.08
Current Ratio 9.73
Debt/Eq 14.34
LT Debt/Eq —
EPS (ttm) -1.46
EPS next Y -1.01
EPS Growth —
Revenue Growth 33.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-02-24
ROA -17.33%
ROE -30.83%
ROIC —
Gross Margin 87.89%
Oper. Margin -58.89%
Profit Margin -59.97%
Shs Outstand 37.87M
Shs Float 25.63M
Insider Own 11.79%
Instit Own 84.77%
Short Float 6.24%
Short Ratio 5.63
Short Interest 1.53M
52W High 24.33
vs 52W High -15.74%
52W Low 10.85
vs 52W Low 88.94%
Beta —
Impl. Vol. 25.00%
Rel Volume 0.61
Avg Volume 282.88K
Volume 171.87K
Target (mean) $27.57
Tgt Median $28.00
Tgt Low $24.00
Tgt High $32.00
# Analysts 7
Recom None
Prev Close $20.16
Price $20.50
Change 1.69%
About

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$27.57
Mean price target
2. Current target
$20.50
Latest analyst target
3. DCF / Fair value
$-11.21
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$20.50
Low
$24.00
High
$32.00
Mean
$27.57

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-28 reit BTIG Buy → Buy $30
2025-12-17 main Canaccord Genuity Buy → Buy $30
2025-12-15 reit BTIG Buy → Buy $30
2025-11-05 main JP Morgan Overweight → Overweight $17
2025-11-05 main TD Cowen Buy → Buy $20
2025-10-21 init Raymond James — → Strong Buy $19
2025-04-04 init Ladenburg Thalmann — → Buy $32
2025-02-26 main Canaccord Genuity Buy → Buy $33
2024-12-09 main TD Cowen Buy → Buy $36
2024-12-09 main Canaccord Genuity Buy → Buy $33
2024-11-13 main Canaccord Genuity Buy → Buy $31
2024-11-05 init JP Morgan — → Overweight $32
2024-11-05 init William Blair — → Outperform —
2024-11-05 init Canaccord Genuity — → Buy $30
2024-11-05 init B of A Securities — → Buy $32
2024-11-05 init TD Cowen — → Buy $31
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-06 CHAO XINGJUAN Chief Executive Officer — 39,000 $18.40 $717,600
2026-04-06 CHAO XINGJUAN Chief Executive Officer — 25,000 $4.70 $117,500
2026-04-01 CHAO XINGJUAN Chief Executive Officer — 97,555 $0.00 $0
2026-04-01 WOO RAYMOND Chief Technology Officer — 30,736 $0.00 $0
2026-04-01 WOO RAYMOND Chief Technology Officer — 11,112 $18.53 $206,244
2026-04-01 WOO RAYMOND Chief Technology Officer — 11,112 $2.24 $48,605
2026-04-01 BLUMBERG SCOTT Chief Financial Officer — 30,736 $0.00 $0
2026-04-01 FOEHR DAVID Officer — 22,050 $0.00 $0
2026-04-01 MANNI JOSEPH S Officer — 30,736 $0.00 $0
2026-03-25 CHAO XINGJUAN Chief Executive Officer — 55,628 $2.24 $151,397
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
89.06
+36.09%
65.44
+44.71%
45.23
+74.47%
25.92
Operating Revenue
89.06
+36.09%
65.44
+44.71%
45.23
+74.47%
25.92
Cost Of Revenue
10.79
+24.10%
8.69
+23.11%
7.06
+59.41%
4.43
Reconciled Cost Of Revenue
10.79
+24.10%
8.69
+23.11%
7.06
+59.41%
4.43
Gross Profit
78.27
+37.93%
56.75
+48.70%
38.16
+77.57%
21.49
Operating Expense
136.68
+41.69%
96.46
+41.43%
68.20
+18.59%
57.51
Research And Development
19.14
+41.15%
13.56
+50.77%
8.99
+24.19%
7.24
Selling General And Administration
117.53
+41.78%
82.90
+40.01%
59.21
+17.78%
50.27
Selling And Marketing Expense
73.08
+48.98%
49.05
+26.03%
38.92
+22.35%
31.81
General And Administrative Expense
44.45
+31.35%
33.84
+66.82%
20.29
+9.90%
18.46
Other Gand A
44.45
+31.35%
33.84
+66.82%
20.29
+9.90%
18.46
Total Expenses
147.47
+40.24%
105.15
+39.71%
75.27
+21.51%
61.94
Operating Income
-58.40
-47.07%
-39.71
-32.18%
-30.04
+16.60%
-36.02
Total Operating Income As Reported
-58.40
-47.07%
-39.71
-32.18%
-30.04
+16.60%
-36.02
EBITDA
-50.18
-34.45%
-37.32
-40.80%
-26.51
+24.40%
-35.06
Normalized EBITDA
-50.18
-40.07%
-35.83
-34.91%
-26.56
+23.88%
-34.89
Reconciled Depreciation
1.34
+17.53%
1.14
+34.71%
0.85
+70.42%
0.50
EBIT
-51.52
-33.95%
-38.46
-40.61%
-27.36
+23.07%
-35.56
Total Unusual Items
—
-1.50
-3216.67%
0.05
+127.43%
-0.17
Total Unusual Items Excluding Goodwill
—
-1.50
-3216.67%
0.05
+127.43%
-0.17
Net Income
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Pretax Income
-53.41
-32.03%
-40.45
-37.35%
-29.45
+20.74%
-37.16
Net Non Operating Interest Income Expense
-1.89
+5.12%
-1.99
+5.05%
-2.10
-30.88%
-1.60
Interest Expense Non Operating
1.89
-5.12%
1.99
-5.05%
2.10
+30.88%
1.60
Net Interest Income
-1.89
+5.12%
-1.99
+5.05%
-2.10
-30.88%
-1.60
Interest Expense
1.89
-5.12%
1.99
-5.05%
2.10
+30.88%
1.60
Other Income Expense
6.88
+452.17%
1.25
-53.61%
2.69
+481.39%
0.46
Other Non Operating Income Expenses
6.88
+150.91%
2.74
+3.94%
2.64
+314.13%
0.64
Gain On Sale Of Security
—
-1.50
-3216.67%
0.05
+127.43%
-0.17
Tax Provision
0.00
0.00
-100.00%
0.01
+450.00%
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Net Income From Continuing Operation Net Minority Interest
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Net Income From Continuing And Discontinued Operation
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Net Income Continuous Operations
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Normalized Income
-53.41
-37.10%
-38.96
-32.01%
-29.51
+20.21%
-36.99
Net Income Common Stockholders
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Diluted EPS
—
-3.39
-168.36%
-1.26
+20.72%
-1.59
Basic EPS
—
-3.39
-168.36%
-1.26
+20.72%
-1.59
Basic Average Shares
—
11.95
-48.77%
23.32
+0.00%
23.32
Diluted Average Shares
—
11.95
-48.77%
23.32
+0.00%
23.32
Diluted NI Availto Com Stockholders
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
195.80
-13.14%
225.41
+282.56%
58.92
-31.85%
86.46
Current Assets
186.72
-14.06%
217.27
+318.13%
51.96
-34.88%
79.80
Cash Cash Equivalents And Short Term Investments
159.26
-18.06%
194.37
+463.47%
34.49
-49.45%
68.23
Cash And Cash Equivalents
40.48
-79.18%
194.37
+463.47%
34.49
-49.45%
68.23
Other Short Term Investments
118.78
0.00
—
—
Receivables
15.05
+38.38%
10.88
+36.74%
7.96
+50.24%
5.29
Accounts Receivable
15.05
+38.38%
10.88
+36.74%
7.96
+50.24%
5.29
Inventory
7.29
+5.06%
6.94
+18.22%
5.87
+44.00%
4.08
Raw Materials
4.99
+21.76%
4.09
+20.23%
3.40
+67.24%
2.04
Finished Goods
2.30
-18.99%
2.84
+15.43%
2.46
+20.79%
2.04
Current Deferred Assets
2.21
+20.30%
1.84
+21.25%
1.51
+47.23%
1.03
Other Current Assets
2.91
-10.58%
3.25
+52.58%
2.13
+82.83%
1.17
Total Non Current Assets
9.09
+11.61%
8.14
+16.97%
6.96
+4.51%
6.66
Net PPE
4.33
-2.68%
4.45
+18.95%
3.74
-3.51%
3.87
Gross PPE
7.03
+14.58%
6.14
+20.22%
5.11
+7.86%
4.73
Accumulated Depreciation
-2.71
-59.93%
-1.69
-23.68%
-1.37
-59.07%
-0.86
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.25
+13.04%
1.10
+0.00%
1.10
+30.96%
0.84
Construction In Progress
0.22
-62.80%
0.59
+51.42%
0.39
+287.00%
0.10
Other Properties
4.71
+29.61%
3.64
+11.36%
3.27
-5.28%
3.45
Leases
0.85
+5.19%
0.81
+132.76%
0.35
+1.75%
0.34
Non Current Deferred Assets
2.18
+17.75%
1.85
+49.68%
1.24
+30.04%
0.95
Other Non Current Assets
2.58
+39.90%
1.84
-7.16%
1.98
+8.18%
1.83
Total Liabilities Net Minority Interest
40.47
+18.16%
34.25
-79.99%
171.17
-0.97%
172.86
Current Liabilities
19.19
+47.74%
12.99
-39.87%
21.60
+118.98%
9.86
Payables And Accrued Expenses
10.08
+48.15%
6.80
+32.37%
5.14
+32.27%
3.89
Payables
2.84
+148.29%
1.14
+56.15%
0.73
+73.05%
0.42
Accounts Payable
2.84
+148.29%
1.14
+56.15%
0.73
+73.05%
0.42
Current Accrued Expenses
7.24
+27.93%
5.66
+28.43%
4.41
+27.29%
3.46
Pensionand Other Post Retirement Benefit Plans Current
7.09
+61.38%
4.39
+40.20%
3.13
+32.71%
2.36
Current Debt And Capital Lease Obligation
1.10
+1.56%
1.09
-91.31%
12.53
+300.35%
3.13
Current Debt
—
—
11.83
+373.32%
2.50
Other Current Borrowings
—
—
11.83
+373.32%
2.50
Current Capital Lease Obligation
1.10
+1.56%
1.09
+56.77%
0.69
+10.33%
0.63
Current Deferred Liabilities
0.10
+4.12%
0.10
-52.91%
0.21
-39.94%
0.34
Current Deferred Revenue
0.10
+4.12%
0.10
-52.91%
0.21
-39.94%
0.34
Other Current Liabilities
0.82
+34.32%
0.61
+2.35%
0.59
+307.53%
0.15
Total Non Current Liabilities Net Minority Interest
21.28
+0.09%
21.26
-85.79%
149.57
-8.23%
162.99
Long Term Debt And Capital Lease Obligation
21.17
+1.43%
20.87
+1144.60%
1.68
-88.89%
15.09
Long Term Debt
19.81
+1.29%
19.56
—
12.72
Long Term Capital Lease Obligation
1.36
+3.50%
1.31
-21.65%
1.68
-29.27%
2.37
Non Current Deferred Liabilities
0.00
-100.00%
0.03
-31.82%
0.04
0.00
Non Current Deferred Revenue
0.00
-100.00%
0.03
-31.82%
0.04
0.00
Other Non Current Liabilities
0.11
-70.22%
0.36
-19.27%
0.44
-9.82%
0.49
Preferred Securities Outside Stock Equity
—
0.00
-100.00%
147.41
+0.00%
147.41
Stockholders Equity
155.34
-18.74%
191.16
+270.30%
-112.25
-29.92%
-86.40
Common Stock Equity
155.30
-18.75%
191.13
+270.27%
-112.25
-29.92%
-86.40
Capital Stock
0.04
+5.56%
0.04
+620.00%
0.01
+0.00%
0.01
Common Stock
0.00
0.00
-100.00%
0.01
+0.00%
0.01
Preferred Stock
0.04
+5.56%
0.04
0.00
—
Share Issued
37.49
+4.56%
35.85
+5.39%
34.02
+0.00%
34.02
Ordinary Shares Number
37.49
+4.56%
35.85
+5.39%
34.02
+0.00%
34.02
Additional Paid In Capital
375.50
+4.87%
358.07
+2415.97%
14.23
+33.99%
10.62
Retained Earnings
-220.36
-31.99%
-166.94
-31.98%
-126.49
-30.37%
-97.03
Gains Losses Not Affecting Retained Earnings
0.16
0.00
—
—
Other Equity Adjustments
0.16
—
—
—
Total Equity Gross Minority Interest
155.34
-18.74%
191.16
+270.30%
-112.25
-29.92%
-86.40
Total Capitalization
175.15
-16.88%
210.72
+287.72%
-112.25
-52.35%
-73.68
Working Capital
167.53
-17.99%
204.28
+572.80%
30.36
-56.58%
69.94
Invested Capital
175.11
-16.89%
210.69
+309.81%
-100.42
-41.08%
-71.18
Total Debt
22.28
+1.44%
21.96
+54.60%
14.20
-22.04%
18.22
Capital Lease Obligations
2.46
+2.62%
2.40
+1.31%
2.37
-20.97%
3.00
Net Tangible Assets
155.34
-18.74%
191.16
+270.30%
-112.25
-29.92%
-86.40
Tangible Book Value
155.30
-18.75%
191.13
+270.27%
-112.25
-29.92%
-86.40
Preferred Stock Equity
0.04
+5.56%
0.04
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-40.81
-16.45%
-35.04
-20.18%
-29.16
+8.88%
-32.00
Cash Flow From Continuing Operating Activities
-40.81
-16.45%
-35.04
-20.18%
-29.16
+8.88%
-32.00
Net Income From Continuing Operations
-53.41
-32.03%
-40.45
-37.30%
-29.46
+20.72%
-37.16
Depreciation Amortization Depletion
1.34
+17.53%
1.14
+34.71%
0.85
+70.42%
0.50
Depreciation And Amortization
1.34
+17.53%
1.14
+34.71%
0.85
+70.42%
0.50
Other Non Cash Items
0.31
-28.80%
0.44
+28.20%
0.34
-1.15%
0.35
Stock Based Compensation
12.22
+125.89%
5.41
+102.05%
2.68
-66.22%
7.93
Operating Gains Losses
0.10
-93.46%
1.59
+1096.24%
0.13
-51.28%
0.27
Gain Loss On Investment Securities
—
1.50
+3216.67%
-0.05
-127.43%
0.17
Gain Loss On Sale Of PPE
0.10
+9.47%
0.10
-47.51%
0.18
—
Change In Working Capital
0.63
+119.96%
-3.17
+14.20%
-3.70
+4.81%
-3.88
Change In Receivables
-4.89
-39.10%
-3.51
-2.36%
-3.43
+13.29%
-3.96
Changes In Account Receivables
-4.17
-42.83%
-2.92
-9.89%
-2.66
+13.16%
-3.06
Change In Inventory
-0.35
+67.13%
-1.07
+40.47%
-1.79
+5.68%
-1.90
Change In Prepaid Assets
0.34
+130.78%
-1.12
-16.17%
-0.96
-178.10%
-0.35
Change In Payables And Accrued Expense
5.97
+119.49%
2.72
+9.86%
2.48
+16.80%
2.12
Change In Accrued Expense
4.22
+71.04%
2.47
+13.99%
2.17
+8.57%
2.00
Change In Payable
1.75
+598.00%
0.25
-19.09%
0.31
+149.19%
0.12
Change In Account Payable
1.75
+598.00%
0.25
-19.09%
0.31
+149.19%
0.12
Change In Other Working Capital
-0.03
+78.86%
-0.12
-32.26%
-0.09
-197.89%
0.10
Change In Other Current Assets
-0.41
-538.46%
-0.07
-157.52%
0.11
+2.73%
0.11
Investing Cash Flow
-118.14
-7292.80%
-1.60
+9.36%
-1.76
-26.02%
-1.40
Cash Flow From Continuing Investing Activities
-118.14
-7292.80%
-1.60
+9.36%
-1.76
-26.02%
-1.40
Net PPE Purchase And Sale
-0.77
+42.76%
-1.34
-36.32%
-0.98
-90.50%
-0.52
Purchase Of PPE
-0.77
+42.76%
-1.34
-36.32%
-0.98
-90.50%
-0.52
Capital Expenditure
-0.77
+42.76%
-1.34
-36.32%
-0.98
-90.50%
-0.52
Net Investment Purchase And Sale
-116.61
0.00
—
—
Purchase Of Investment
-210.81
0.00
—
—
Sale Of Investment
94.20
0.00
—
—
Net Other Investing Changes
-0.76
-192.64%
-0.26
+66.92%
-0.78
+11.66%
-0.88
Financing Cash Flow
5.05
-97.43%
196.52
+7073.60%
-2.82
-105.66%
49.80
Cash Flow From Continuing Financing Activities
5.05
-97.43%
196.52
+7073.60%
-2.82
-105.66%
49.80
Net Issuance Payments Of Debt
0.00
-100.00%
7.91
+310.80%
-3.75
-9515.38%
-0.04
Issuance Of Debt
0.00
-100.00%
7.91
0.00
0.00
Repayment Of Debt
—
0.00
+100.00%
-3.75
-9515.38%
-0.04
Long Term Debt Issuance
0.00
-100.00%
7.91
0.00
0.00
Long Term Debt Payments
—
0.00
+100.00%
-3.75
-9515.38%
-0.04
Net Long Term Debt Issuance
0.00
-100.00%
7.91
+310.80%
-3.75
-9515.38%
-0.04
Net Common Stock Issuance
0.00
-100.00%
192.83
0.00
—
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-0.31
Proceeds From Stock Option Exercised
5.44
+381.58%
1.13
+21.14%
0.93
+505.19%
0.15
Net Other Financing Charges
-0.39
+92.79%
-5.35
—
—
Changes In Cash
-153.89
-196.26%
159.88
+573.84%
-33.74
-305.68%
16.40
Beginning Cash Position
194.37
+463.47%
34.49
-49.45%
68.23
+31.65%
51.83
End Cash Position
40.48
-79.18%
194.37
+463.47%
34.49
-49.45%
68.23
Free Cash Flow
-41.58
-14.27%
-36.38
-20.71%
-30.14
+7.31%
-32.52
Interest Paid Supplemental Data
1.89
-2.97%
1.95
+12.57%
1.73
+6.51%
1.63
Amortization Of Securities
-2.01
0.00
—
—
Common Stock Issuance
0.00
-100.00%
192.83
0.00
—
Issuance Of Capital Stock
0.00
-100.00%
192.83
0.00
-100.00%
50.00
Net Preferred Stock Issuance
—
—
0.00
-100.00%
49.69
Preferred Stock Issuance
—
—
0.00
-100.00%
50.00
Preferred Stock Payments
—
—
0.00
+100.00%
-0.31
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category